INAB IN8bio, Inc.
$0.96▼ -0.17%
Healthcare
Other
Volume 12.2K
Avg Volume (10D) 47.2K
Key Metrics & Fundamentals
Market Cap
$9.46M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.87 - 2.73
% vs 50 MA
-17.62%
% vs 200 MA
-34.80%
RSI-14
34.6
MACD Histogram
-0.0400
Beta (1Y vs SPY)
1.39
Free Cash Flow
-$3.98M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$4.48M
COGS
–
Operating Exp
$4.94M
Operating Income
-$4.94M
EBIT
-$4.94M
Pretax Income
-$4.78M
Net Income
-$4.78M
EPS (Diluted)
-0.25
Price & Volume History
Loading chart…
Recent News
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 6, 2026 4:00 PM ET
IN8bio to Present at Sidoti Small-Cap Virtual Conference
GlobeNewswire · Sep 22, 2026 4:00 PM ET
IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 10, 2026 8:00 AM ET
IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development
GlobeNewswire · Sep 9, 2026 8:00 AM ET
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Aug 10, 2026 4:01 PM ET
IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire · Aug 6, 2026 4:01 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See INAB's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.